Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Paediatrics & Neonatology

Choose Topic

Racial disparities in treatment and outcomes of children with type 1 diabetes

Pediatric Diabetes | Mar 05, 2021 Pediatric Endocrinology General Pediatrics

Human plasma‐derived alpha ₁ ‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study

Pediatric Diabetes | Mar 05, 2021 General Pediatrics Pediatric Endocrinology

Association of physical activity metrics with indicators of cardiovascular function and control in children with and without type 1 diabetes

Pediatric Diabetes | Mar 04, 2021 Pediatric Cardiology Pediatric Endocrinology General Pediatrics

The effect of coexisting autoimmune thyroiditis in children with type 1 diabetes on optical coherence tomography results

Pediatric Diabetes | Mar 04, 2021 Pediatric Endocrinology General Pediatrics Peds Allergy/Immunology Pediatric Radiology

Association of first trimester anesthesia with risk of congenital heart defects in offspring

International Journal of Epidemiology | Mar 03, 2021 Pediatric Cardiology Developmental Peds General Pediatrics

Antenatal corticosteroid therapy in late preterm delivery: A nationwide population‐based retrospective study in Taiwan

BJOG: An International Journal of Obstetrics and Gynaecology | Mar 03, 2021 Neonatology General Pediatrics Clinical Pharmacology Epidemiology

Preeclampsia and long‐term health outcomes for mother and infant: An umbrella review

BJOG: An International Journal of Obstetrics and Gynaecology | Mar 03, 2021 General Pediatrics Developmental Peds Neonatology

Association of hemoglobin levels in the first trimester and at 26 to 30 weeks with fetal and neonatal outcomes: A secondary analyses of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

BJOG: An International Journal of Obstetrics and Gynaecology | Mar 03, 2021 General Pediatrics Neonatology

The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab

Pediatric Nephrology | Mar 03, 2021 Nephrology/Urology Clinical Pharmacology General Pediatrics

Duration of neonatal intensive care unit exposure associated with decreased risk of atopic dermatitis

Pediatric Dermatology | Mar 03, 2021 General Pediatrics Pediatric Dermatology Neonatology

« Prev 1 … 101 102 103 104 105 … 709 Next »

Racial disparities in treatment and outcomes of children with type 1 diabetes

Human plasma‐derived alpha ₁ ‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study

Association of physical activity metrics with indicators of cardiovascular function and control in children with and without type 1 diabetes

The effect of coexisting autoimmune thyroiditis in children with type 1 diabetes on optical coherence tomography results

Association of first trimester anesthesia with risk of congenital heart defects in offspring

Antenatal corticosteroid therapy in late preterm delivery: A nationwide population‐based retrospective study in Taiwan

Preeclampsia and long‐term health outcomes for mother and infant: An umbrella review

Association of hemoglobin levels in the first trimester and at 26 to 30 weeks with fetal and neonatal outcomes: A secondary analyses of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab

Duration of neonatal intensive care unit exposure associated with decreased risk of atopic dermatitis

Awareness for COPD: MCQ challenge

BRI or BMI: What is More Efficient?

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

Racial disparities in treatment and outcomes of children with type 1 diabetes

Human plasma‐derived alpha 1 ‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study

Association of physical activity metrics with indicators of cardiovascular function and control in children with and without type 1 diabetes

The effect of coexisting autoimmune thyroiditis in children with type 1 diabetes on optical coherence tomography results

Association of first trimester anesthesia with risk of congenital heart defects in offspring

Antenatal corticosteroid therapy in late preterm delivery: A nationwide population‐based retrospective study in Taiwan

Preeclampsia and long‐term health outcomes for mother and infant: An umbrella review

Association of hemoglobin levels in the first trimester and at 26 to 30 weeks with fetal and neonatal outcomes: A secondary analyses of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab

Duration of neonatal intensive care unit exposure associated with decreased risk of atopic dermatitis

Awareness for COPD: MCQ challenge

BRI or BMI: What is More Efficient?

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

Select Specialty

Select Topic

Human plasma‐derived alpha ₁ ‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study